NCT07322263 2026-04-17
Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
University of Iowa
Phase 2 Recruiting
Clinical Trials
29 trialsNCT02311959 2026-04-14
MAPAM-01
Institut Claudius Regaud
Phase 3 Completed
NCT06056843 2026-04-03
PUD
International Agency for Research on Cancer
Phase NA Completed
NCT06876038 2026-03-19
Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions
University of Massachusetts, Boston
Phase 2 Not yet recruiting
NCT06115486 2026-02-04
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Phase NA Recruiting
NCT04057209 2025-10-07
VoiceS
Insel Gruppe AG, University Hospital Bern
Phase NA Recruiting
NCT07189793 2025-09-24
OHAI-NMIBC-01
First Affiliated Hospital of Wenzhou Medical University
Phase 2 Not yet recruiting
NCT06263582 2025-08-19
Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT04755517 2025-01-13
HPV400
Tampere University Hospital
Phase NA Enrolling by invitation
NCT06389448 2024-05-07
Comparison of pCLE and EB in Gastric Lesion Diagnosis
Huazhong University of Science and Technology
Phase NA Recruiting
NCT06324825 2024-03-22
Fuzheng Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial
Peking University First Hospital
Phase NA Unknown
NCT03268993 2023-04-07
Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer
University of Pittsburgh
Phase NA Completed
NCT02698293 2022-11-22
PDT Plus Vitamin D3 for Anal Dysplasia
Abramson Cancer Center at Penn Medicine
Phase 1 Withdrawn
NCT02039388 2022-09-02
LUSTIC
Medical University of Vienna
Phase NA Completed
NCT04823871 2022-09-02
EHUD
Medical University of Vienna
Phase NA Completed
NCT02901548 2022-07-29
Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
NCT03182959 2021-06-21
Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer
University of Arizona
Phase EARLY_PHASE1 Completed
NCT00402779 2020-04-21
Erlotinib Prevention of Oral Cancer (EPOC)
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00260598 2018-09-13
LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer
University of Pittsburgh
Phase 2 Terminated
NCT03106610 2018-05-24
Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT01901991 2017-08-11
Localization of Nonpalpable Breast Lesions
Rigshospitalet, Denmark
Phase NA Completed
NCT03195218 2017-06-22
UH3
Barretos Cancer Hospital
Phase NA Unknown
NCT03075098 2017-03-09
Colposcopy in Detection of Oral Epithelial Dysplasia
Cairo University
Phase NA Unknown
NCT02217358 2016-09-08
Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions
University Hospital Ostrava
Phase NA Completed
NCT02397252 2016-08-17
CASSIS
McGill University
Phase NA Completed
NCT01192204 2015-08-14
Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention
Ohio State University
Phase 1/2 Completed
NCT01924117 2013-08-16
HPV
Materno-Perinatal Hospital of the State of Mexico
Phase NA Completed
NCT00410865 2011-12-07
Wild Type p53 Adenovirus for Oral Premalignancies
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT00352404 2006-07-14
Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia
Johannes Gutenberg University Mainz
Phase 3 Completed